{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:59:27Z","timestamp":1792454367805,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019481","name":"Southwestern Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019481","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013748","name":"Hope Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM152319"],"award-info":[{"award-number":["T32 GM152319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32GM131945-03"],"award-info":[{"award-number":["5T32GM131945-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ebiom.2025.106044","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:28:17Z","timestamp":1764250097000},"page":"106044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["First-in-human high dose AAV9 intrathecal gene therapy for paediatric CLN7 disease: a phase 1, open-label, single ascending dose, non-randomised clinical trial"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-8201","authenticated-orcid":false,"given":"Benjamin M.","family":"Greenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berge","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad","family":"Messahel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1602-0252","authenticated-orcid":false,"given":"Veronica Bordes","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamza","family":"Dahshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily R.","family":"Nettesheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alagar R.","family":"Muthukumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalayarasan","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Iannaccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganapathy","family":"Varadarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima N.","family":"Kayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.106044_bib1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/brain\/awn366","article-title":"Mutations in CLN7\/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis","volume":"132","author":"Kousi","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2025.106044_bib2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1086\/518902","article-title":"The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter","volume":"81","author":"Siintola","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ebiom.2025.106044_bib3","first-page":"1","article-title":"Evaluation of 36 patients from Turkey with neuronal ceroid lipofuscinosis: clinical, neurophysiological, neuroradiological and histopathologic studies","volume":"46","author":"Top\u00e7u","year":"2004","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.ebiom.2025.106044_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ymgme.2018.09.009","article-title":"A newly generated neuronal cell model of CLN7 disease reveals aberrant lysosome motility and impaired cell survival","volume":"126","author":"von Kleist","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ebiom.2025.106044_bib5","doi-asserted-by":"crossref","first-page":"E530","DOI":"10.1002\/humu.20975","article-title":"Mutations in MFSD8\/CLN7 are a frequent cause of variant-late infantile neuronal ceroid lipofuscinosis","volume":"30","author":"Aiello","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ebiom.2025.106044_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.807515","article-title":"Case report: novel MFSD8 variants in a Chinese family with neuronal ceroid lipofuscinoses 7","volume":"13","author":"Qiao","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ebiom.2025.106044_bib7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10072-021-05067-8","article-title":"Neuronal ceroid lipofuscinosis: genetic and phenotypic spectrum of 14 patients from Turkey","volume":"42","author":"Kose","year":"2021","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ebiom.2025.106044_bib8","first-page":"20","article-title":"High diagnostic yield of direct sanger sequencing in the diagnosis of neuronal ceroid lipofuscinoses","volume":"50","author":"Jilani","year":"2019","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ebiom.2025.106044_bib9","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00439-023-02556-y","article-title":"Clinical and genetic characterization of neuronal ceroid lipofuscinoses (NCLs) in 29 Iranian patients: identification of 11 novel mutations","volume":"142","author":"Panjeshahi","year":"2023","journal-title":"Human Genet"},{"key":"10.1016\/j.ebiom.2025.106044_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ejmg.2014.09.004","article-title":"Clinico-pathological manifestations of variant late infantile neuronal ceroid lipofuscinosis (vLINCL) caused by a novel mutation in MFSD8 gene","volume":"57","author":"Mandel","year":"2014","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.ebiom.2025.106044_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109576","article-title":"Exome sequencing is an efficient tool for variant late-infantile neuronal ceroid lipofuscinosis molecular diagnosis","volume":"9","author":"Pati\u00f1o","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.106044_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10048-008-0153-1","article-title":"A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis","volume":"10","author":"Stogmann","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ebiom.2025.106044_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207958","article-title":"Next-generation sequencing identifies unexpected genotype-phenotype correlations in patients with retinitis pigmentosa","volume":"13","author":"Birtel","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.106044_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejpn.2014.07.008","article-title":"Rett-like onset in late-infantile neuronal ceroid lipofuscinosis (CLN7) caused by compound heterozygous mutation in the MFSD8 gene and review of the literature data on clinical onset signs","volume":"19","author":"Craiu","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ebiom.2025.106044_bib15","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.3390\/ijms23042271","article-title":"A novel, apparently silent variant in","volume":"23","author":"Reith","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2025.106044_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10048-009-0185-1","article-title":"Neuronal ceroid lipofuscinosis caused by MFSD8 mutations: a common theme emerging","volume":"10","author":"Aldahmesh","year":"2009","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ebiom.2025.106044_bib17","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/cge.13673","article-title":"Functional characterization of novel MFSD8 pathogenic variants anticipates neurological involvement in juvenile isolated maculopathy","volume":"97","author":"Bauwens","year":"2020","journal-title":"Clin Genet"},{"key":"10.1016\/j.ebiom.2025.106044_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12881-018-0669-7","article-title":"A novel MFSD8 mutation in a Russian patient with neuronal ceroid lipofuscinosis type 7: a case report","volume":"19","author":"Kozina","year":"2018","journal-title":"BMC Med Genet 08 25"},{"key":"10.1016\/j.ebiom.2025.106044_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/genes14020245","article-title":"Linear diagnostic procedure elicited by clinical genetics and validated by mRNA analysis in neuronal ceroid Lipofuscinosis 7 associated with a novel non-canonical splice site variant in","volume":"14","author":"Pasquetti","year":"2023","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ebiom.2025.106044_bib20","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.3390\/ijms23084294","article-title":"Contribution of whole-genome sequencing and transcript analysis to decipher retinal diseases associated with","volume":"23","author":"Poncet","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2025.106044_bib21","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/hum.2022.163","article-title":"Biodistribution of adeno-associated virus gene therapy following cerebrospinal fluid-directed administration","volume":"34","author":"Chen","year":"2023","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ebiom.2025.106044_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146286","article-title":"AAV9\/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease","volume":"132","author":"Chen","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2025.106044_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164575","article-title":"Intrathecal AAV9\/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies","volume":"133","author":"Chen","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2025.106044_bib24","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1172\/JCI133953","article-title":"Krabbe disease successfully treated via monotherapy of intrathecal gene therapy","volume":"130","author":"Bradbury","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2025.106044_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa2307952","article-title":"Intrathecal gene therapy for giant axonal neuropathy","volume":"390","author":"Bharucha-Goebel","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2025.106044_bib26","series-title":"Mullen Scales of Early Learning","author":"Mullen","year":"1995"},{"key":"10.1016\/j.ebiom.2025.106044_bib27","series-title":"Vineland adaptive behavior scales","author":"Sparrow","year":"2016"},{"key":"10.1016\/j.ebiom.2025.106044_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11136-006-9134-8","article-title":"Reliability and validity of the infant and toddler quality of life questionnaire (ITQOL) in a general population and respiratory disease sample","volume":"16","author":"Raat","year":"2007","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ebiom.2025.106044_bib29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11136-018-2057-3","article-title":"Psychometric properties of the quality of life inventory-disability (QI-Disability) measure","volume":"28","author":"Downs","year":"2019","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ebiom.2025.106044_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.omtm.2022.01.013","article-title":"Characterization of AAV-mediated dorsal root ganglionopathy","volume":"24","author":"Buss","year":"2022","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425004888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425004888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:38:44Z","timestamp":1778873924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425004888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"alternative-id":["S2352396425004888"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106044","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-human high dose AAV9 intrathecal gene therapy for paediatric CLN7 disease: a phase 1, open-label, single ascending dose, non-randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.106045","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106044"}}